Search Results 101-110 of 16534 for HMB loading phase
There are also less common very early (phase 0) and later (phase 4) phases. ... load within 6 months of screening and enrollment are eligible for this trial.
The primary objectives of this study are to evaluate the effect of Elafibranor treatment compared to placebo on 1) histological improvement and 2) all-cause ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
PURPOSE: This randomized phase II trial is studying giving bendamustine hydrochloride and rituximab together with or without bortezomib followed by rituximab ...
Therefore, these robust preclinical findings will be tested in the proposed phase I trial. Participation eligibility. Participant eligibility includes age, ...
There are also less common very early (phase 0) and later (phase 4) phases. ... undetectable HBV viral load on suppressive therapy within 28 days prior to
Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and ...
About this study. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.